Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Nova Pharmaceuticals Australasia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (273)
Cancellation by sponsor (72)
Cancellation or suspension (24)
Prescription medicine registration (5)
Cancellation for failure to pay annual charge (1)
Listed medicine compliance report (1)

Date

2024 (38)
2023 (28)
2022 (22)
2021 (28)
2020 (44)
2019 (29)
2018 (43)
2017 (50)
2016 (14)
2015 (8)
2014 (3)
2013 (14)
2012 (19)
2011 (9)
2010 (9)
2009 (4)
2008 (1)
2007 (6)
2006 (3)
2005 (2)
2004 (2)

Results for "[search-keyword]"

Search

Sponsor content

376 result(s) found, displaying 161 to 170

PHARMACY HEALTH SORE THROAT SPRAY benzydamine hydrochloride 1.5 mg/mL solution bottle (311422)

12 November 2018

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PHARMACY HEALTH SORE THROAT SPRAY benzydamine hydrochloride 1.5 mg/mL solution bottle.
PHARMACY HEALTH SORE THROAT SPRAY FORTE benzydamine hydrochloride 3.0 mg/mL solution bottle (311423)

12 November 2018

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PHARMACY HEALTH SORE THROAT SPRAY FORTE benzydamine hydrochloride 3.0 mg/mL solution bottle.
PRICELINE SORE THROAT SPRAY FORTE benzydamine hydrochloride 3.0 mg/mL solution bottle (311424)

12 November 2018

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PRICELINE SORE THROAT SPRAY FORTE benzydamine hydrochloride 3.0 mg/mL solution bottle.
PRICELINE SORE THROAT SPRAY benzydamine hydrochloride 1.5 mg/mL solution bottle (311425)

12 November 2018

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PRICELINE SORE THROAT SPRAY benzydamine hydrochloride 1.5 mg/mL solution bottle.
MEDICHOICE IBUPROFEN 200 mg soft gelatin capsule blister pack (red capsules) (311426)

12 November 2018

ARTG

Australian Register of Therapeutic Goods (ARTG) information for MEDICHOICE IBUPROFEN 200 mg soft gelatin capsule blister pack (red capsules).
EnergiX Stamina Effervescent Tablets Cancelled under Section 30(1)(c) of the Act

31 August 2020

Cancellation by sponsor

Requested by Nova Pharmaceuticals Australasia Pty Ltd
EnergiX Immunity Effervescent Tablets Cancelled under Section 30(1)(c) of the Act

31 August 2020

Cancellation by sponsor

Requested by Nova Pharmaceuticals Australasia Pty Ltd
Black & Gold Chest Rub Cancelled under Section 30(1)(c) of the Act

31 August 2020

Cancellation by sponsor

Requested by Nova Pharmaceuticals Australasia Pty Ltd
MEDIX Tea Tree Oil 20% Solution Cancelled under Section 30(1)(c) of the Act

31 August 2020

Cancellation by sponsor

Requested by Nova Pharmaceuticals Australasia Pty Ltd
EnergiX Performance Effervescent Tablets Cancelled under Section 30(1)(c) of the Act

31 August 2020

Cancellation by sponsor

Requested by Nova Pharmaceuticals Australasia Pty Ltd

Pages

First page
Previous page
…
Page 13
Page 14
Page 15
Page 16
Current page 17
Page 18
Page 19
Page 20
Page 21
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.